Neurology
From the Journals
In California, opioids most often prescribed in low-income, mostly white areas
Opioid-related overdose deaths are highest in low-income white areas.
News from the FDA/CDC
FDA issues warnings to companies selling illegal Alzheimer’s treatments
The FDA targeted more than 58 products.
What Your Patients are Hearing
American football and CTE: Is a racial divide inevitable?
Evidence that American football can lead to chronic traumatic encephalopathy (CTE), continues to grow. As a result, some parents are opting to...
Evidence-Based Reviews
Antidepressants for chronic pain
Certain agents may mitigate pain associated with neuropathy, fibromyalgia, headache, and IBS.
Conference Coverage
Asthma, obesity, and the risk for severe sleep apnea in children
CORONADO, CALIF. – The findings could pave the way for studies of asthma pharmacotherapy as a way to treat OSA in...
MDedge Psychcast
Masterclass: First-episode psychosis with Dr. Henry A. Nasrallah
Everything you need to know when you see these patients.
From the Journals
Functional MRI detects consciousness after brain damage
Four brain signal coordination patterns emerge with differences across levels of consciousness.
Evidence-Based Reviews
Can lifestyle modifications delay or prevent Alzheimer’s disease?
Evidence suggests combining lifestyle modifications may yield better cognitive outcomes.
From the Journals
Novel plasma biomarkers may predict preclinical Alzheimer’s disease
The approach will need to be validated and translated “to a simpler automated platform suitable for wider utility.”
What Your Patients are Hearing
Corpora callosa of young football players could be at risk
“To us, it’s more than a question about concussions, it’s a question about long-term cumulative exposure.”
Feature
Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stopped
The molecule will continue to be tested in a study of familial Alzheimer’s in Colombia.